HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption

Early-phase HIV remission (“cure”) trials aim to test interventions developed to eradicate HIV or to sustainably control HIV without antiretroviral treatment (ART). Many remission trials include analytic treatment interruption (ATI) to evaluate interventions, which increases the risk to participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumu, Eunice Akinyi, Henderson, Gail E., Golin, Carol, Kuczynski, Kriste, Ormsby, Nuchanart Q., Peay, Holly L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319831/
https://www.ncbi.nlm.nih.gov/pubmed/37416088
http://dx.doi.org/10.1016/j.jve.2023.100331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319831/
https://www.ncbi.nlm.nih.gov/pubmed/37416088
http://dx.doi.org/10.1016/j.jve.2023.100331

Ejemplares similares